nach oben

Journal of Neurology

Erschienen in:

26.04.2018 | Review

Dilemma of multiple system atrophy and spinocerebellar ataxias

verfasst von: Ming Li, Qianqian Ma, Xing Zhao, Can Wang, Huijie Wu, Jinyao Li, Wei Yang

Erschienen in: Journal of Neurology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Multiple system atrophy (MSA) and spinocerebellar ataxias (SCAs) are both progressive neurodegenerative disorders, which can manifest cerebellar dysfunctions and parkinsonism-related symptoms, although the former is sporadic and the latter is autosomal dominant disease. Routinely, diagnosis is primarily based on clinical information—thorough history and physical examination should be included. Provided family history obtained, distinguishing SCAs from MSA is easy. However, how can we diagnose MSA or SCAs, in case of insufficient and unconvinced clinical symptoms or family history? Especially, familial MSA cases had been reported recently. We may drop into a dilemma resulting from analogous manifestations between MSA and SCAs. Herein, we aim to give a comprehensive introduction of MSA and SCAs, mainly in phenotype and genotype, and then address the connection and difference between them. Recently, some studies had been put forward to figure out the overlapped features between MSA and SCAs. Through this review, we want to discuss the possibility of misdiagnosis between MSA and SCAs.

Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hubsch T, Schols L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Kang JS, Pandolfo M, Schulz JB, Molho S, Diallo A, Klockgether T (2015) Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 14(11):1101–1108. https://doi.org/10.1016/s1474-4422(15)00202-1 CrossRefPubMed

Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249–263. https://doi.org/10.1056/NEJMra1311488 CrossRefPubMed

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676. https://doi.org/10.1212/01.wnl.0000324625.00404.15 CrossRefPubMedPubMedCentral

Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3(5):291–304. https://doi.org/10.1016/s1474-4422(04)00737-9 CrossRef

Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK (2014) Update on novel familial forms of Parkinson’s disease and multiple system atrophy. Parkinsonism Relat Disord 20(Suppl 1):S29-34. https://doi.org/10.1016/s1353-8020(13)70010-5 CrossRefPubMed

Munhoz RP, Teive HA, Raskin S, Werneck LC (2009) CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 111(2):208–210. https://doi.org/10.1016/j.clineuro.2008.09.003 CrossRefPubMed

Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grunwald F, Hilker R (2014) The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Mov Disord 29(3):380–387. https://doi.org/10.1002/mds.25749 CrossRefPubMed

Pedroso JL, Rivero RL, Barsottini OG (2013) “Hot cross bun” sign resembling multiple system atrophy in a patient with Machado-Joseph disease. Arquivos de neuro-psiquiatria 71(10):824. https://doi.org/10.1590/0004-282x20130132 CrossRefPubMed

Berciano J, Boesch S, Perez-Ramos JM, Wenning GK (2006) Olivopontocerebellar atrophy: toward a better nosological definition. Mov Disord 21(10):1607–1613. https://doi.org/10.1002/mds.21052 CrossRefPubMed

10.

Kim HJ, Jeon BS, Shin J, Lee WW, Park H, Jung YJ, Ehm G (2014) Should genetic testing for SCAs be included in the diagnostic workup for MSA? Neurology 83(19):1733–1738. https://doi.org/10.1212/wnl.0000000000000965 CrossRefPubMed

11.

Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schols L, Schicks J, Infante J, Kang JS, Timmann D, Di Fabio R, Masciullo M, Baliko L, Melegh B, Boesch S, Burk K, Peltz A, Schulz JB, Dufaure-Gare I, Klockgether T (2013) Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol 12(7):650–658. https://doi.org/10.1016/s1474-4422(13)70104-2 CrossRefPubMed

12.

Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J (2015) Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14(7):710–719. https://doi.org/10.1016/s1474-4422(15)00058-7 CrossRefPubMedPubMedCentral

13.

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274. https://doi.org/10.1016/s1474-4422(12)70327-7 CrossRefPubMedPubMedCentral

14.

Kim HJ, Jeon BS, Jellinger KA (2015) Diagnosis and differential diagnosis of MSA: boundary issues. J Neurol 262(8):1801–1813. https://doi.org/10.1007/s00415-015-7654-2 CrossRefPubMed

15.

De Joanna G, De Rosa A, Salvatore E, Castaldo I, De Luca N, Izzo R, Manzo V, Filla A, De Michele G (2008) Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. J Neurol Sci 275(1–2):60–63. https://doi.org/10.1016/j.jns.2008.07.015 CrossRefPubMed

16.

Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rub U (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathol 124(1):1–21. https://doi.org/10.1007/s00401-012-1000-x CrossRefPubMed

17.

Jellinger KA (2014) Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord 29(14):1720–1741. https://doi.org/10.1002/mds.26052 CrossRefPubMed

18.

Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K (2015) Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112(38):E5308-5317. https://doi.org/10.1073/pnas.1514475112 CrossRef

19.

Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL, Dickson DW (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol 130(1):93–105. https://doi.org/10.1007/s00401-015-1442-z CrossRefPubMed

20.

Tha KK, Terae S, Tsukahara A, Soma H, Morita R, Yabe I, Ito YM, Sasaki H, Shirato H (2012) Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy. BMC Neurol 12:39. https://doi.org/10.1186/1471-2377-12-39 CrossRefPubMedPubMedCentral

21.

Kasahara S, Miki Y, Kanagaki M, Kondo T, Yamamoto A, Morimoto E, Okada T, Ito H, Takahashi R, Togashi K (2012) “Hot cross bun” sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. Eur J Radiol 81(10):2848–2852. https://doi.org/10.1016/j.ejrad.2011.12.012 CrossRefPubMed

22.

Hekman KE, Gomez CM (2015) The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability. J Neurol Neurosurg Psychiatr 86(5):554–561. https://doi.org/10.1136/jnnp-2014-308421 CrossRef

23.

Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain J Neurol 125(Pt 5):1070–1083CrossRef

24.

Lee YC, Liu CS, Wu HM, Wang PS, Chang MH, Soong BW (2009) The ‘hot cross bun’ sign in the patients with spinocerebellar ataxia. Eur J Neurol 16(4):513–516. https://doi.org/10.1111/j.1468-1331.2008.02524.x CrossRefPubMed

25.

Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ (2005) Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol 26(9):2238–2242PubMed

26.

Kim JS, Yang JJ, Lee DK, Lee JM, Youn J, Cho JW (2015) Cognitive Impairment and Its Structural Correlates in the Parkinsonian Subtype of Multiple System Atrophy. Neuro Degener Dis 15(5):294–300. https://doi.org/10.1159/000430953 CrossRef

27.

Lee MJ, Shin JH, Seoung JK, Lee JH, Yoon U, Oh JH, Jung DS, Kim EJ (2016) Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 23(1):92–100. https://doi.org/10.1111/ene.12796 CrossRefPubMed

28.

Bleasel JM, Hsiao JH, Halliday GM, Kim WS (2013) Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. J Parkinson’s Dis 3(3):331–339. https://doi.org/10.3233/jpd-130203 CrossRef

29.

Multiple-System Atrophy Research C (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369 (3):233–244. https://doi.org/10.1056/NEJMoa1212115 CrossRef

30.

Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30(3):436–437. https://doi.org/10.1002/mds.26138 CrossRefPubMed

31.

Wen XD, Li HF, Wang HX, Ni W, Dong Y, Wu ZY (2015) Mutation Analysis of COQ2 in Chinese Patients with Cerebellar Subtype of Multiple System Atrophy. CNS Neurosci Therapeut 21(8):626–630. https://doi.org/10.1111/cns.12412 CrossRef

32.

Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case–control study and meta-analysis of the literature. Neurol Sci 37(3):423–430. https://doi.org/10.1007/s10072-015-2414-8 CrossRefPubMed

33.

Sharma M, Wenning G, Kruger R (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371 (1):80–81. https://doi.org/10.1056/NEJMc1311763#SA2 CrossRefPubMed

34.

Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Poyhonen M, Paetau A (2014) Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol Aging 35(9):2180.e2181–2185. https://doi.org/10.1016/j.neurobiolaging.2014.03.024 CrossRef

35.

Federoff M, Price TR, Sailer A, Scholz S, Hernandez D, Nicolas A, Singleton AB, Nalls M, Houlden H (2016) Genome-wide estimate of the heritability of Multiple System Atrophy. Parkinsonism Relat Disord 22:35–41. https://doi.org/10.1016/j.parkreldis.2015.11.005 CrossRefPubMed

36.

Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O’Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Hoglinger GU, Wullner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H (2016) A genome-wide association study in multiple system atrophy. Neurology 87(15):1591–1598. https://doi.org/10.1212/wnl.0000000000003221 CrossRefPubMedPubMedCentral

37.

Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA (2014) LRRK2 exonic variants and risk of multiple system atrophy. Neurology 83(24):2256–2261. https://doi.org/10.1212/wnl.0000000000001078 CrossRefPubMedPubMedCentral

38.

Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, Hawkes H, Cammarota A, Merello M (2014) Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol 21(4):607–615CrossRef

39.

Smeets CJ, Verbeek DS (2016) Climbing fibers in spinocerebellar ataxia: a mechanism for the loss of motor control. Neurobiol Dis 88:96–106. https://doi.org/10.1016/j.nbd.2016.01.009 CrossRefPubMed

40.

Costa Mdo C, Paulson HL (2012) Toward understanding Machado-Joseph disease. Prog Neurobiol 97(2):239–257. https://doi.org/10.1016/j.pneurobio.2011.11.006 CrossRefPubMed

41.

Yu GY, Howell MJ, Roller MJ, Xie TD, Gomez CM (2005) Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to SCA6. Ann Neurol 57(3):349–354. https://doi.org/10.1002/ana.20371 CrossRefPubMed

42.

Rub U, Schols L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW, Deller T (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Progr Neurobiol 104:38–66. https://doi.org/10.1016/j.pneurobio.2013.01.001 CrossRef

43.

Montes-Brown J, Machado A, Estevez M, Carricarte C, Velazquez-Perez L (2012) Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2. Acta Neurol Scand 125(1):24–29. https://doi.org/10.1111/j.1600-0404.2011.01494.x CrossRefPubMed

44.

Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Granata R, Wanschitz J, Wagner M, Gizewski ER, Poewe W, Wenning GK, Boesch S (2018) Autonomic function testing in spinocerebellar ataxia type 2. Clin Auton Res. https://doi.org/10.1007/s10286-018-0504-4 CrossRefPubMedPubMedCentral

45.

Yeh T, Lu C, Chou Y et al (2005) Autonomic dysfunction in machado-joseph disease. Arch Neurol 62(4):630–636. https://doi.org/10.1001/archneur.62.4.630 CrossRefPubMed

46.

Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, Hawkes M, Cammarota A, Merello M (2014) Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol 21(4):607–615. https://doi.org/10.1111/ene.12350 CrossRefPubMed

47.

Seidel K, Siswanto S, Fredrich M, Bouzrou M, den Dunnen WFA, Ozerden I, Korf HW, Melegh B, de Vries JJ, Brunt ER, Auburger G, Rub U (2017) On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3. Brain Pathol (Zurich Switz) 27(3):345–355. https://doi.org/10.1111/bpa.12412 CrossRef

48.

Pulst SM (2016) Degenerative ataxias, from genes to therapies: The 2015 Cotzias Lecture. Neurology 86(24):2284–2290. https://doi.org/10.1212/wnl.0000000000002777 CrossRefPubMedPubMedCentral

49.

Matilla-Duenas A, Ashizawa T, Brice A, Magri S, McFarland KN, Pandolfo M, Pulst SM, Riess O, Rubinsztein DC, Schmidt J, Schmidt T, Scoles DR, Stevanin G, Taroni F, Underwood BR, Sanchez I (2014) Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum 13(2):269–302. https://doi.org/10.1007/s12311-013-0539-y CrossRefPubMedPubMedCentral

50.

Guimaraes RP, D’Abreu A, Yasuda CL, Franca MC Jr, Silva BH, Cappabianco FA, Bergo FP, Lopes-Cendes IT, Cendes F (2013) A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Dis 28(8):1125–1132. https://doi.org/10.1002/mds.25451 CrossRef

51.

Schols L, Reimold M, Seidel K, Globas C, Brockmann K, Hauser TK, Auburger G, Burk K, den Dunnen W, Reischl G, Korf HW, Brunt ER, Rub U (2015) No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra. Brain J Neurol 138(Pt 11):3316–3326. https://doi.org/10.1093/brain/awv255 CrossRef

52.

Brockmann K, Reimold M, Globas C, Hauser TK, Walter U, Machulla HJ, Rolfs A, Schols L (2012) PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17. J Nucl Med 53(7):1074–1080. https://doi.org/10.2967/jnumed.111.101543 CrossRefPubMed

53.

Knight MA, Hernandez D, Diede SJ, Dauwerse HG, Rafferty I, van de Leemput J, Forrest SM, Gardner RJ, Storey E, van Ommen GJ, Tapscott SJ, Fischbeck KH, Singleton AB (2008) A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20. Hum Mol Genet 17(24):3847–3853. https://doi.org/10.1093/hmg/ddn283 CrossRefPubMedPubMedCentral

54.

Burk K, Skalej M, Dichgans J (2001) Pontine MRI hyperintensities (“the cross sign”) are not pathognomonic for multiple system atrophy (MSA). Mov Dis 16(3):535CrossRef

55.

Kim HJ, Stamelou M, Jeon B (2016) Multiple system atrophy-mimicking conditions: diagnostic challenges. Parkinsonism & related disorders 22 Suppl 1:S12-15. https://doi.org/10.1016/j.parkreldis.2015.09.003 CrossRef

56.

Guo YC, Lin JJ, Liao YC, Tsai PC, Lee YC, Soong BW (2014) Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization. Neurology 83(17):1554–1561. https://doi.org/10.1212/wnl.0000000000000909 CrossRefPubMed

57.

Fahl CN, Branco LM, Bergo FP, D’Abreu A, Lopes-Cendes I, Franca MC Jr (2015) Spinal cord damage in Machado–Joseph disease. Cerebellum 14(2):128–132. https://doi.org/10.1007/s12311-014-0619-7 CrossRefPubMed

58.

Martins CR Jr, Martinez AR, de Rezende TJ, Branco LM, Pedroso JL, Barsottini OG, Lopes-Cendes I, Franca MC Jr. (2017) Spinal Cord Damage in Spinocerebellar Ataxia Type 1. Cerebellum (Lond Engl). https://doi.org/10.1007/s12311-017-0854-9 CrossRef

59.

Lukas C, Hahn HK, Bellenberg B, Hellwig K, Globas C, Schimrigk SK, Koster O, Schols L (2008) Spinal cord atrophy in spinocerebellar ataxia type 3 and 6: impact on clinical disability. J Neurol 255(8):1244–1249. https://doi.org/10.1007/s00415-008-0907-6 CrossRefPubMed

60.

Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schols L, Mariotti C, van de Warrenburg BP, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G (2014) Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 137(Pt 9):2444–2455. https://doi.org/10.1093/brain/awu174 CrossRefPubMedPubMedCentral

61.

Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH (2013) Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol 70(10):1302–1304. https://doi.org/10.1001/jamaneurol.2013.443 CrossRefPubMedPubMedCentral

62.

Dong Y, Wu JJ, Wu ZY (2015) Identification of 46 CAG repeats within PPP2R2B as probably the shortest pathogenic allele for SCA12. Parkinsonism Relat Disord 21(4):398–401. https://doi.org/10.1016/j.parkreldis.2015.01.006 CrossRefPubMed

63.

Park H, Kim HJ, Jeon BS (2015) Parkinsonism in spinocerebellar ataxia. BioMed Res Int 2015:125273. https://doi.org/10.1155/2015/125273 CrossRefPubMedPubMedCentral

64.

Doherty KM, Warner TT, Lees AJ (2014) Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma. Mov Dis 29(1):36–38. https://doi.org/10.1002/mds.25770 CrossRef

65.

Itoh K, Kasai T, Tsuji Y, Saito K, Mizuta I, Harada Y, Sudoh S, Mizuno T, Nakagawa M, Fushiki S (2014) Definite familial multiple system atrophy with unknown genetics. Neuropathology 34(3):309–313. https://doi.org/10.1111/neup.12092 CrossRefPubMed

66.

Chort A, Alves S, Marinello M, Dufresnois B, Dornbierer JG, Tesson C, Latouche M, Baker DP, Barkats M, El Hachimi KH, Ruberg M, Janer A, Stevanin G, Brice A, Sittler A (2013) Interferon beta induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice. Brain J Neurol 136(Pt 6):1732–1745. https://doi.org/10.1093/brain/awt061 CrossRef

67.

Muglan JA, Menon S, Jog MS (2016) Pearls & Oy-sters: spinocerebellar ataxia type 3 presenting with cervical dystonia without ataxia. Neurology 86(1):e1-3. https://doi.org/10.1212/wnl.0000000000002232 CrossRefPubMed

68.

Maas RPPWM, van Gaalen J, Klockgether T, van de Warrenburg BPC (2015) The preclinical stage of spinocerebellar ataxias. Neurology 85(1):1–9. https://doi.org/10.1212/WNL.0000000000001711 CrossRef

69.

Hwang I, Sohn CH, Kang KM, Jeon BS, Kim HJ, Choi SH, Yun TJ, Kim JH (2015) Differentiation of parkinsonism-predominant multiple system atrophy from idiopathic parkinson disease using 3T susceptibility-weighted MR imaging, focusing on putaminal change and lesion asymmetry. AJNR Am J Neuroradiol 36(12):2227–2234. https://doi.org/10.3174/ajnr.A4442 CrossRefPubMed

70.

Kim JM, Jeong HJ, Bae YJ, Park SY, Kim E, Kang SY, Oh ES, Kim KJ, Jeon B, Kim SE, Cho ZH, Kim YB (2016) Loss of substantia nigra hyperintensity on 7 T MRI of Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Parkinsonism Relat Disord 26:47–54. https://doi.org/10.1016/j.parkreldis.2016.01.023 CrossRefPubMed

71.

Reiter E, Mueller C, Pinter B, Krismer F, Scherfler C, Esterhammer R, Kremser C, Schocke M, Wenning GK, Poewe W, Seppi K (2015) Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord 30(8):1068–1076. https://doi.org/10.1002/mds.26171 CrossRefPubMed

72.

Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown RG, Leigh PN, Dell’Acqua F, Simmons A (2014) Diffusion tensor imaging of Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One 9(11):e112638. https://doi.org/10.1371/journal.pone.0112638 CrossRefPubMedPubMedCentral

73.

Rozenfeld MN, Nemeth AJ, Walker MT, Mohan P, Wang X, Parrish TB, Opal P (2015) An investigation of diffusion imaging techniques in the evaluation of spinocerebellar ataxia and multisystem atrophy. J Clin Neurosci 22(1):166–172. https://doi.org/10.1016/j.jocn.2014.08.006 CrossRefPubMed

Titel: Dilemma of multiple system atrophy and spinocerebellar ataxias
verfasst von: Ming Li
Qianqian Ma
Xing Zhao
Can Wang
Huijie Wu
Jinyao Li
Wei Yang
Publikationsdatum: 26.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 12/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8876-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies

The role of clinical and neuroimaging features in the diagnosis of CADASIL

36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry

Migraine prophylactic management in neurology and primary care (2006–2015)

Vitamin D for the treatment of multiple sclerosis: a meta-analysis